See the DrugPatentWatch profile for cosentyx

Based on the information available, there is currently no evidence to suggest that taking Cosentyx (secukinumab) will affect the safety or efficacy of the COVID-19 vaccine. However, it is always recommended to consult with a healthcare provider before receiving any vaccine, especially for individuals taking medications like Cosentyx.

Cosentyx is a prescription medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking a specific protein in the body that causes inflammation.

The Centers for Disease Control and Prevention (CDC) recommends that individuals who are taking medications or have underlying medical conditions receive the COVID-19 vaccine. Still, the CDC does not provide specific guidance on Cosentyx and the vaccine.

It is important to note that clinical trials for COVID-19 vaccines did not specifically examine the safety and efficacy of the vaccines in individuals taking Cosentyx. Therefore, it is essential to consult with a healthcare provider to determine the best course of action.

In summary, while there is no evidence to suggest that taking Cosentyx will affect the safety or efficacy of the COVID-19 vaccine, it is always recommended to consult with a healthcare provider before receiving any vaccine.

Sources:

1. Cosentyx (secukinumab) injection, for subcutaneous use [Prescribing Information]. (2021). Novartis Pharmaceuticals Corporation. <https://www.novartis.com/sites/www.novartis.com/files/cosentyx-pi.pdf>
2. COVID-19 Vaccines. (2022). Centers for Disease Control and Prevention. <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html>
3. DrugPatentWatch. (2022). Cosentyx (secukinumab) Drug Profile. <https://www.drugpatentwatch.com/drugs/cosentyx>